MARKET
IPO

AROG

Arog Pharmaceuticals
AROG
NASDAQ
Upcoming IPOs
Expected Listing Date: - -
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-
-
-
-
Biotechnology & Medical Research
2018-09-28
Public Filing
View Prospectus
Pending
Offering
Price Range: Pending
Shares to be Issued: Pending
Pending
Offering End Date
Offering Price: Pending
Post IPO Outstanding: 3246.00K
Listed
No Data
About AROG
AROG Pharmaceuticals, INC. is a United States-based company that operates as a biopharmaceutical company. The Company develops lead investigational drug candidate, crenolanib and a related class of benzimidazole-based compounds to become treatment options for cancer indications with high unmet medical need.

Webull offers Arog Pharmaceuticals stock information, including NASDAQ: AROG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AROG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AROG stock methods without spending real money on the virtual paper trading platform.